Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 71
1.
Pharmacol Res ; 158: 104877, 2020 08.
Article En | MEDLINE | ID: mdl-32407958

Oxidative/nitrosative stress and neuroinflammation are critical pathological processes in cerebral ischemia-reperfusion injury, and their intimate interactions mediate neuronal damage, blood-brain barrier (BBB) damage and hemorrhagic transformation (HT) during ischemic stroke. We review current progress towards understanding the interactions of oxidative/nitrosative stress and inflammatory responses in ischemic brain injury. The interactions between reactive oxygen species (ROS)/reactive nitrogen species (RNS) and innate immune receptors such as TLR2/4, NOD-like receptor, RAGE, and scavenger receptors are crucial pathological mechanisms that amplify brain damage during cerebral ischemic injury. Furthermore, we review the current progress of omics and systematic biology approaches for studying complex network regulations related to oxidative/nitrosative stress and inflammation in the pathology of ischemic stroke. Targeting oxidative/nitrosative stress and neuroinflammation could be a promising therapeutic strategy for ischemic stroke treatment. We then review recent advances in discovering compounds from medicinal herbs with the bioactivities of simultaneously regulating oxidative/nitrosative stress and pro-inflammatory molecules for minimizing ischemic brain injury. These compounds include sesamin, baicalin, salvianolic acid A, 6-paradol, silymarin, apocynin, 3H-1,2-Dithiole-3-thione, (-)-epicatechin, rutin, Dl-3-N-butylphthalide, and naringin. We finally summarize recent developments of the omics and systematic biology approaches for exploring the molecular mechanisms and active compounds of Traditional Chinese Medicine (TCM) formulae with the properties of antioxidant and anti-inflammation for neuroprotection. The comprehensive omics and systematic biology approaches provide powerful tools for exploring therapeutic principles of TCM formulae and developing precision medicine for stroke treatment.


Biological Products/administration & dosage , Ischemic Stroke/drug therapy , Metabolomics/trends , Nitrosative Stress/physiology , Oxidative Stress/physiology , Proteomics/trends , Animals , Anti-Inflammatory Agents/administration & dosage , Antioxidants/administration & dosage , Inflammation/drug therapy , Inflammation/metabolism , Ischemic Stroke/metabolism , Metabolomics/methods , Nitrosative Stress/drug effects , Oxidative Stress/drug effects , Proteomics/methods , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Treatment Outcome
2.
Int J Mol Sci ; 20(23)2019 Nov 30.
Article En | MEDLINE | ID: mdl-31801293

The gastric secretory trefoil factor family (TFF) peptides xP1 and xP4 are the Xenopus laevis orthologs of mammalian TFF1 and TFF2, respectively. The aim of this study was to analyze the molecular forms of xP1 and xP4 in the X. laevis gastric mucosa by FPLC. xP1 mainly occurred in a monomeric low-molecular-mass form and only a minor subset is associated with the mucus fraction. The occurrence of monomeric xP1 is unexpected because of its odd number of cysteine residues. Probably a conserved acidic residue flanking Cys55 allows monomeric secretion. Furthermore, Cys55 is probably post-translationally modified. For the first time, we hypothesize that the free thiol of monomeric xP1-and probably also its mammalian ortholog TFF1-could have a protective scavenger function, e.g., for reactive oxygen/nitrogen species. In contrast, xP4 mainly occurs in a high-molecular-mass form and is non-covalently bound to a mucin similarly as TFF2. In vitro binding studies with radioactively labeled porcine TFF2 even showed binding to X. laevis gastric mucin. Thus, xP4 is expected to bind as a lectin to an evolutionary conserved sugar epitope of the X. laevis ortholog of mucin MUC6 creating a tight mucus barrier. Taken together, xP1 and xP4 appear to have different gastric protective functions.


Amphibian Proteins/chemistry , Free Radical Scavengers/chemistry , Gastric Mucosa/metabolism , Protective Agents/chemistry , Protein Processing, Post-Translational , Trefoil Factor-1/chemistry , Amphibian Proteins/isolation & purification , Amphibian Proteins/metabolism , Amphibian Proteins/pharmacology , Animals , Free Radical Scavengers/isolation & purification , Free Radical Scavengers/metabolism , Free Radical Scavengers/pharmacology , Molecular Weight , Mucins/chemistry , Mucins/metabolism , Protective Agents/isolation & purification , Protective Agents/metabolism , Protective Agents/pharmacology , Protein Binding , Protein Isoforms/chemistry , Protein Isoforms/isolation & purification , Protein Isoforms/metabolism , Protein Isoforms/pharmacology , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Swine , Trefoil Factor-1/isolation & purification , Trefoil Factor-1/metabolism , Trefoil Factor-1/pharmacology , Xenopus laevis/physiology
3.
Infect Immun ; 87(10)2019 10.
Article En | MEDLINE | ID: mdl-31308080

Macrophages are critical mediators of innate immunity and must be overcome for bacterial pathogens to cause disease. The Gram-positive bacterium Staphylococcus aureus produces virulence factors that impede macrophages and other immune cells. We previously determined that production of the metabolic cofactor lipoic acid by the lipoic acid synthetase, LipA, blunts macrophage activation. A ΔlipA mutant was attenuated during infection and was more readily cleared from the host. We hypothesized that bacterial lipoic acid synthesis perturbs macrophage antimicrobial functions and therefore hinders the clearance of S. aureus Here, we found that enhanced innate immune cell activation after infection with a ΔlipA mutant was central to attenuation in vivo, whereas a growth defect imparted by the lipA mutation made a negligible contribution to overall clearance. Macrophages recruited to the site of infection with the ΔlipA mutant produced larger amounts of bactericidal reactive oxygen species (ROS) and reactive nitrogen species (RNS) than those recruited to the site of infection with the wild-type strain or the mutant strain complemented with lipA ROS derived from the NADPH phagocyte oxidase complex and RNS derived from the inducible nitric oxide synthetase, but not mitochondrial ROS, were critical for the restriction of bacterial growth under these conditions. Despite enhanced antimicrobial immunity upon primary infection with the ΔlipA mutant, we found that the host failed to mount an improved recall response to secondary infection. Our data suggest that lipoic acid synthesis in S. aureus promotes bacterial persistence during infection through limitation of ROS and RNS generation by macrophages. Broadly, this work furthers our understanding of the intersections between bacterial metabolism and immune responses to infection.


Bacterial Proteins/genetics , Gene Expression Regulation, Bacterial , Macrophages, Peritoneal/metabolism , Staphylococcal Infections/metabolism , Staphylococcus aureus/genetics , Thioctic Acid/biosynthesis , Animals , Bacterial Proteins/metabolism , Female , Host-Pathogen Interactions/immunology , Macrophage Activation , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/microbiology , Male , Mice , Microbial Viability , Mutation , NADPH Oxidases/genetics , NADPH Oxidases/immunology , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/immunology , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/immunology , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/immunology , Reactive Oxygen Species/metabolism , Staphylococcal Infections/immunology , Staphylococcal Infections/microbiology , Staphylococcus aureus/metabolism , Thioctic Acid/pharmacology
4.
Nitric Oxide ; 90: 55-65, 2019 09 01.
Article En | MEDLINE | ID: mdl-31271864

Roots have a noteworthy plasticity: due to different stress conditions their architecture can change to favour seedling vigour and yield stability. The development of the root system is regulated by a complex and diverse signalling network, which besides hormonal factors, includes reactive oxygen (ROS) - and nitrogen species (RNS). The delicate balance of the endogenous signal system can be affected by various environmental stimuli, such as the excess of essential heavy metals, like zinc (Zn). Zn at low concentration, is able to induce the morphological and physiological adaptation of the root system, but in excess it exerts toxic effects on plants. In this study the effect of a low, growth-inducing, and a high, growth inhibiting Zn concentrations on the early development of Brassica napus (L.) root architecture and the underlying nitro-oxidative mechanisms were studied in a soil-filled rhizotron system. The growth-inhibiting Zn treatment resulted in elevated protein tyrosine nitration due to the imbalance in ROS and RNS homeostasis, however its pattern was not changed compared to the control. This nitro-oxidative stress was accompanied by serious changes in the cell wall composition and decrease in the cell proliferation and viability, due to the high Zn uptake and disturbed microelement homeostasis in the root tips. During the positive root growth response, a tyrosine nitration-pattern reorganisation was observed; there were no substantial changes in ROS and RNS balance and the viability and proliferation of the root tips' meristematic zone decreased to a lesser extent, as a result of a lower Zn uptake. The obtained results suggest that Zn in different amounts triggers different root growth responses accompanied by distinct changes in the pattern and strength of tyrosine nitration, proposing that nitrosative processes have an important role in the stress-induced root growth responses.


Brassica napus/drug effects , Plant Roots/drug effects , Reactive Nitrogen Species/antagonists & inhibitors , Zinc/pharmacology , Brassica napus/growth & development , Oxidation-Reduction , Oxidative Stress/drug effects , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism
5.
Free Radic Biol Med ; 142: 123-131, 2019 10.
Article En | MEDLINE | ID: mdl-30818057

Perinatal asphyxia is characterized by oxygen deprivation and lack of perfusion in the perinatal period, leading to hypoxic-ischemic encephalopathy and sequelae such as cerebral palsy, mental retardation, cerebral visual impairment, epilepsy and learning disabilities. On cellular level PA is associated with a decrease in oxygen and glucose leading to ATP depletion and a compromised mitochondrial function. Upon reoxygenation and reperfusion, the renewed availability of oxygen gives rise to not only restoration of cell function, but also to the activation of multiple detrimental biochemical pathways, leading to secondary energy failure and ultimately, cell death. The formation of reactive oxygen species, nitric oxide and peroxynitrite plays a central role in the development of subsequent neurological damage. In this review we give insight into the pathophysiology of perinatal asphyxia, discuss its clinical relevance and summarize current neuroprotective strategies related to therapeutic hypothermia, ischemic postconditioning and pharmacological interventions. The review will also focus on the possible neuroprotective actions and molecular mechanisms of the selective neuronal and inducible nitric oxide synthase inhibitor 2-iminobiotin that may represent a novel therapeutic agent for the treatment of hypoxic-ischemic encephalopathy, both in combination with therapeutic hypothermia in middle- and high-income countries, as well as stand-alone treatment in low-income countries.


Asphyxia Neonatorum/therapy , Biotin/analogs & derivatives , Hypothermia, Induced/methods , Hypoxia-Ischemia, Brain/therapy , Neuroprotective Agents/therapeutic use , Reactive Nitrogen Species/antagonists & inhibitors , Allopurinol/therapeutic use , Asphyxia Neonatorum/metabolism , Asphyxia Neonatorum/physiopathology , Biotin/therapeutic use , Cerebral Palsy/prevention & control , Clinical Trials as Topic , Epilepsy/prevention & control , Erythropoietin/therapeutic use , Female , Humans , Hypoxia-Ischemia, Brain/metabolism , Hypoxia-Ischemia, Brain/physiopathology , Infant, Newborn , Intellectual Disability/prevention & control , Ischemic Postconditioning/methods , Melatonin/therapeutic use , Pregnancy , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism
6.
Plant Foods Hum Nutr ; 74(1): 135-140, 2019 Mar.
Article En | MEDLINE | ID: mdl-30644023

Jabuticaba has a high concentration of phenolic compounds, which have a significant antioxidant capacity. Methodologies have been developed to evaluate the ability of plant extracts to fight free radicals such as H2O2, O2•-, HOCl, ONOO- and ROO•. Thus, the capacity of deactivation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in peel and seed extracts of five varieties of jabuticaba was evaluated. Sabará peel (SFP) deactivated HOCl with IC50 9.24 µg. mL-1; Paulista seed (PF) deactivated O2•- with IC50 16.15 µg. mL-1; Coroada seed (CFP) deactivated ONOO- with IC50 3.84 µg. mL-1; the peel of CFP deactivated ONOO- with IC50 5.88 µg. mL-1; the peel of SFP deactivated the ROO• at 918.16 µmol TE. g-1; and Sabará seed deactivated H2O2 with 49.11% inhibition at a concentration of 125 µg. mL-1 of extract. These results demonstrate the high antioxidant potential of this fruit, indicating that it could be extremely beneficial to human health.


Antioxidants/pharmacology , Myrtaceae/chemistry , Plant Extracts/pharmacology , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Oxygen Species/antagonists & inhibitors , Fruit/chemistry , Humans , Plant Extracts/chemistry , Seeds/chemistry
7.
J Diet Suppl ; 16(5): 491-505, 2019.
Article En | MEDLINE | ID: mdl-29958039

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with multiple pathological consequences such as oxidative stress, inflammation, apoptosis, cholinergic deficit, amyloid plaques, and tangles formation. Hence, development of drugs with multiple targets will be effective in the treatment of AD. The present study aims at evaluation of the neuroprotective effect of Gelidiella acerosa against amyloid beta 25-35 (Aß 25-35) induced toxicity in PC12 cells. The antioxidative effect was evaluated by monitoring levels of antioxidant enzymes. Protection against ROS-induced damage was assessed by the measurement of lipid peroxidation, protein carbonyl content (PCC), 2',7'-dichlorofluorescein diacetate (DCFH-DA) fluorescence, and nitric oxide (NO) production. The cholinesterase (ChE) inhibitory activity was also evaluated. The antiapoptotic activity was verified by caspase-3 activity. The results of antioxidant assays suggest that G. acerosa significantly (P < .05) restores the levels of antioxidant enzymes. Moreover, the seaweed extract was found to prevent the formation of intracellular ROS induced by Aß 25-35 and thereby protects PC12 cells from macromolecular damage. The study demonstrated that G. acerosa inhibits ChE activity significantly (P < .05) in PC12 cells. The significant decrease (P < .05) in the level of caspase-3 activity indicates that the seaweed has anti-apoptotic activity. Hence, the outcome of this study signifies the neuroprotective effect of G. acerosa targeting multiple pathological consequences of AD.


Amyloid beta-Peptides/toxicity , Neuroprotective Agents/pharmacology , Peptide Fragments/toxicity , Plant Extracts/pharmacology , Rhodophyta/chemistry , Animals , Antioxidants/pharmacology , Apoptosis/drug effects , Cholinesterase Inhibitors , Oxidative Stress/drug effects , PC12 Cells , Rats , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Oxygen Species/antagonists & inhibitors
8.
Free Radic Biol Med ; 129: 155-168, 2018 12.
Article En | MEDLINE | ID: mdl-30227272

Mitochondrial dysfunction characterized by impaired bioenergetics, oxidative stress and aldehydic load is a hallmark of heart failure. Recently, different research groups have provided evidence that selective activation of mitochondrial detoxifying systems that counteract excessive accumulation of ROS, RNS and reactive aldehydes is sufficient to stop cardiac degeneration upon chronic stress, such as heart failure. Therefore, pharmacological and non-pharmacological approaches targeting mitochondria detoxification may play a critical role in the prevention or treatment of heart failure. In this review we discuss the most recent findings on the central role of mitochondrial dysfunction, oxidative stress and aldehydic load in heart failure, highlighting the most recent preclinical and clinical studies using mitochondria-targeted molecules and exercise training as effective tools against heart failure.


Antioxidants/therapeutic use , Biomimetic Materials/therapeutic use , Cardiotonic Agents/therapeutic use , Heart Failure/therapy , Mitochondria, Heart/drug effects , Ubiquinone/analogs & derivatives , Aldehydes/antagonists & inhibitors , Aldehydes/metabolism , Animals , Clinical Trials as Topic , Disease Models, Animal , Drug Evaluation, Preclinical , Energy Metabolism/drug effects , Exercise , Heart Failure/metabolism , Heart Failure/pathology , Humans , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Mitochondria, Heart/metabolism , Mitochondria, Heart/pathology , Oxidative Stress/drug effects , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Superoxide Dismutase/chemistry , Ubiquinone/therapeutic use
9.
J Physiol Biochem ; 74(3): 359-367, 2018 Aug.
Article En | MEDLINE | ID: mdl-29713940

A large number of researches have led to a substantial growth of knowledge about exercise and oxidative stress. Initial investigations reported that physical exercise generates free radical-mediated damages to cells; however, in recent years, studies have shown that regular exercise can upregulate endogenous antioxidants and reduce oxidative damage. Yet, strenuous exercise perturbs the antioxidant system by increasing the reactive oxygen species (ROS) content. These alterations in the cellular environment seem to occur in an exercise type-dependent manner. The source of ROS generation during exercise is debatable, but now it is well established that both contracting and relaxing skeletal muscles generate reactive oxygen species and reactive nitrogen species. In particular, exercises of higher intensity and longer duration can cause oxidative damage to lipids, proteins, and nucleotides in myocytes. In this review, we summarize the ROS effects and interplay of antioxidants in skeletal muscle during physical exercise. Additionally, we discuss how ROS-mediated signaling influences physical exercise in antioxidant system.


Antioxidants/therapeutic use , Exercise , Healthy Lifestyle , Muscle, Skeletal/metabolism , Oxidative Stress , Reactive Oxygen Species/antagonists & inhibitors , Reperfusion Injury/prevention & control , Animals , Anti-Inflammatory Agents, Non-Steroidal/metabolism , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antioxidants/metabolism , Cell Survival , Diet, Healthy , Dietary Supplements , Humans , Mitochondria, Muscle/enzymology , Mitochondria, Muscle/immunology , Mitochondria, Muscle/metabolism , Muscle Fatigue , Muscle, Skeletal/blood supply , Muscle, Skeletal/immunology , Muscle, Skeletal/physiopathology , Myalgia/etiology , Myalgia/prevention & control , Myositis/immunology , Myositis/prevention & control , Oxygen Consumption , Physical Exertion , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism , Reperfusion Injury/immunology , Reperfusion Injury/metabolism , Reperfusion Injury/physiopathology
10.
Biofactors ; 44(1): 36-49, 2018 Jan.
Article En | MEDLINE | ID: mdl-29193412

Resveratrol, a natural polyphenolic compound, is found in various kinds of fruits, plants, and their commercial products such as red wine. It has been demonstrated to exhibit a variety of health-promoting effects including prevention and/or treatment of cardiovascular diseases, inflammation, diabetes, neurodegeneration, aging, and cancer. Cellular defensive properties of resveratrol can be explained through its ability of either directly neutralizing reactive oxygen species/reactive nitrogen species (ROS/RNS) or indirectly upregulating the expression of cellular defensive genes. As a direct antioxidant agent, resveratrol scavenges diverse ROS/RNS as well as secondary organic radicals with mechanisms of hydrogen atom transfer and sequential proton loss electron transfer, thereby protecting cellular biomolecules from oxidative damage. Resveratrol also enhances the expression of various antioxidant defensive enzymes such as heme oxygenase 1, catalase, glutathione peroxidase, and superoxide dismutase as well as the induction of glutathione level responsible for maintaining the cellular redox balance. Such defenses could be achieved by regulating various signaling pathways including sirtuin 1, nuclear factor-erythroid 2-related factor 2 and nuclear factor κB. This review provides current understanding and information on the role of resveratrol in cellular defense system against oxidative stress. © 2017 BioFactors, 44(1):36-49, 2018.


Antioxidants/pharmacology , Gene Expression Regulation/drug effects , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Oxygen Species/antagonists & inhibitors , Stilbenes/pharmacology , Animals , Catalase/genetics , Catalase/metabolism , Glutathione Peroxidase/genetics , Glutathione Peroxidase/metabolism , Heme Oxygenase-1/genetics , Heme Oxygenase-1/metabolism , Humans , NF-E2 Transcription Factor/genetics , NF-E2 Transcription Factor/metabolism , NF-kappa B/genetics , NF-kappa B/metabolism , Oxidative Stress/drug effects , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism , Resveratrol , Signal Transduction , Sirtuin 1/genetics , Sirtuin 1/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism
11.
Biosci Biotechnol Biochem ; 81(8): 1569-1575, 2017 Aug.
Article En | MEDLINE | ID: mdl-28463548

Oxidation of low-density lipoprotein (LDL) by reactive oxygen species (ROS) and reactive nitrogen species (RNS) has been suggested to be involved in the onset of atherosclerosis. Oolong tea contains unique polyphenols including oolonghomobisflavan A (OFA). In this study, the effects of OFA on LDL oxidation by ROS and RNS were investigated in vitro. OFA suppressed formation of cholesterol ester hydroperoxides in LDL oxidized by peroxyl radical and peroxynitrite, and formation of thiobarbituric acid reactive substances in LDL oxidized by Cu2+. In addition, OFA inhibited fragmentation, carbonylation, and nitration of apolipoprotein B-100 (apo B-100) in the oxidized LDL, in which heparin-binding activity of apo B-100 was protected by OFA. Our results suggest that OFA exhibits antioxidant activity against both lipid peroxidation and oxidative modification of apo B-100 in LDL oxidized by ROS and RNS. Polyphenols in oolong tea may prevent atherosclerosis by reducing oxidative stress.


Camellia sinensis/chemistry , Flavonoids/chemistry , Lipoproteins, LDL/antagonists & inhibitors , Polyphenols/chemistry , Apolipoprotein B-100/antagonists & inhibitors , Cations, Divalent , Cholesterol Esters/antagonists & inhibitors , Copper/chemistry , Flavonoids/isolation & purification , Heparin/chemistry , Humans , Kinetics , Lipid Peroxidation , Oxidation-Reduction , Peroxides/antagonists & inhibitors , Peroxynitrous Acid/antagonists & inhibitors , Plant Extracts/chemistry , Polyphenols/isolation & purification , Protein Binding , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Oxygen Species/antagonists & inhibitors , Thiobarbiturates/antagonists & inhibitors
12.
Curr Top Med Chem ; 17(12): 1336-1370, 2017.
Article En | MEDLINE | ID: mdl-28049396

Reactive species are produced in biological system because of redox reactions. The imbalance in pro-oxidant and antioxidant homeostasis leads to the production of toxic reactive oxygen and nitrogen species like hydrogen peroxide, organic peroxides, hydroxyl radicals, superoxide anion and nitric oxide. Inactivation of metabolic enzymes, oxidation of biomolecules and cellular damage are some of the prominent characteristics of reactive species. Similarly, oxidative stress has been associated with more than one hundred (100) pathologies such as atherosclerosis, diabetes, cardiovascular diseases, pancreatic and liver diseases, joint disorders, cardiac fibrosis, acute respiratory distress syndrome, neurological diseases (amyotrophic lateral sclerosis, Huntington's disorder, Parkinson's disease and Alzheimer's disease), ageing and cancer etc. The toxicity of reactive species is balanced by the integrated antioxidant systems, which include enzymatic and non-enzymatic antioxidants. Antioxidant therapies or defenses protect the biological sites by removing or quenching the free radicals (prooxidants). Medicinal plants can not only protect the oxidative damage, but also play a vital role in health maintenance and prevention of chronic degenerative diseases. This review will provide a valuable discussion of one hundred (100) well known medicinal plants, which may add to the optimization of antioxidants rank. Besides, some of the antioxidant evaluation techniques or mechanisms via which medicinal plants act as antioxidants are also described.


Antioxidants/pharmacology , Oxidative Stress/drug effects , Plants, Medicinal/chemistry , Antioxidants/chemistry , Humans , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism
13.
J Physiol Biochem ; 73(2): 175-185, 2017 May.
Article En | MEDLINE | ID: mdl-27864790

We and others have demonstrated a protective role for pacing postconditioning (PPC) against ischemia/reperfusion (I/R) injury in the heart; however, the underlying mechanisms behind these protective effects are not completely understood. In this study, we wanted to further characterize PPC-mediated cardiac protection, specifically identify optimal pacing sites; examine the role of oxidative stress; and test the existence of a potential synergistic effect between PPC and adenosine. Isolated rat hearts were subjected to coronary occlusion followed by reperfusion. PPC involved three, 30 s, episodes of alternating left ventricular (LV) and right atrial (RA) pacing. Multiple pacing protocols with different pacing electrode locations were used. To test the involvement of oxidative stress, target-specific agonists or antagonists were infused at the beginning of reperfusion. Hemodynamic data were digitally recorded, and cardiac enzymes, oxidant, and antioxidant status were chemically measured. Pacing at the LV or RV but not at the heart apex or base significantly (P < 0.001) protected against ischemia-reperfusion injury. PPC-mediated protection was completely abrogated in the presence of reactive oxygen species (ROS) scavenger, ebselen; peroxynitrite (ONOO-) scavenger, uric acid; and nitric oxide synthase inhibitor, L-NAME. Nitric oxide (NO) donor, snap, however significantly (P < 0.05) protected the heart against I/R injury in the absence of PPC. The protective effects of PPC were significantly improved by adenosine. PPC-stimulated protection can be achieved by alternating LV and RA pacing applied at the beginning of reperfusion. NO, ROS, and the product of their interaction ONOO- play a significant role in PPC-induced cardiac protection. Finally, the protective effects of PPC can be synergized with adenosine.


Adenosine/therapeutic use , Cardiotonic Agents/therapeutic use , Coronary Circulation/drug effects , Heart Ventricles/drug effects , Ischemic Postconditioning/methods , Myocardial Reperfusion Injury/prevention & control , Oxidative Stress/drug effects , Adenosine/adverse effects , Animals , Antioxidants/adverse effects , Antioxidants/therapeutic use , Cardiotonic Agents/adverse effects , Combined Modality Therapy/adverse effects , Enzyme Inhibitors/adverse effects , Enzyme Inhibitors/therapeutic use , Free Radical Scavengers/adverse effects , Free Radical Scavengers/therapeutic use , Heart Ventricles/metabolism , Heart Ventricles/physiopathology , In Vitro Techniques , Ischemic Postconditioning/adverse effects , Male , Myocardial Reperfusion Injury/metabolism , Myocardial Reperfusion Injury/physiopathology , Nitric Oxide Donors/adverse effects , Nitric Oxide Donors/therapeutic use , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Rats, Wistar , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Reproducibility of Results
14.
J Nutr Biochem ; 37: 94-100, 2016 11.
Article En | MEDLINE | ID: mdl-27648880

The aim of this study was to assess the influence of hydroxytyrosol (HT) on cardiovascular biomarkers and morphometric parameters of the arterial wall in streptozotocin-diabetic rats. Seven groups of rats (N=10 per group) were studied for 2 months: nondiabetic rats (NDR), diabetic rats treated with saline (DR) and DR treated with HT (0.5, 1, 2.5, 5 and 10 mg kg-1 day-1 p.o.). DR had higher platelet aggregation values, higher thromboxane B2, plasma lipid peroxidation, 3-nitrotyrosine, oxidized LDL (oxLDL), myeloperoxidase, vascular cell adhesion molecule 1 (VCAM-1) and interleukin-1ß (IL-1ß) concentrations, and lower aortic 6-keto-prostaglandin F1α and nitric oxide production than NDR. Aortic wall area and smooth muscle cell count were also higher in DR than in NDR. HT significantly reduced both oxidative and nitrosative stress, oxLDL concentration, VCAM-1 and inflammatory mediators, platelet aggregation and thromboxane B2 production. Morphometric values in the aortic wall were reduced to values near those in NDR. In conclusion, HT influenced the major biochemical processes leading to diabetic vasculopathy, and reduced cell proliferation in the vascular wall in this experimental model.


Antioxidants/therapeutic use , Cardiovascular Diseases/prevention & control , Diabetes Mellitus, Experimental/diet therapy , Diabetic Angiopathies/prevention & control , Diabetic Cardiomyopathies/prevention & control , Dietary Supplements , Phenylethyl Alcohol/analogs & derivatives , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antioxidants/administration & dosage , Aorta, Abdominal , Biomarkers/blood , Biomarkers/metabolism , Cardiovascular Diseases/complications , Cardiovascular Diseases/immunology , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Diabetic Angiopathies/immunology , Diabetic Cardiomyopathies/immunology , Endothelium, Vascular/immunology , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/blood , Inflammation Mediators/metabolism , Lipid Peroxidation , Lipoproteins, LDL/blood , Male , Muscle, Smooth, Vascular/immunology , Muscle, Smooth, Vascular/metabolism , Muscle, Smooth, Vascular/pathology , Oxidative Stress , Phenylethyl Alcohol/administration & dosage , Phenylethyl Alcohol/therapeutic use , Platelet Aggregation , Rats, Wistar , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/blood , Reactive Nitrogen Species/metabolism , Streptozocin
15.
Fiziol Zh (1994) ; 61(1): 3-9, 2015.
Article Uk | MEDLINE | ID: mdl-26040029

In experiments in vivo the effect of nanocerium (cerium oxide nanoparticles) on the stability of red blood cells to acid hemolysis, levels of both ROS and RNS generation and H2S pools in plasma and erythrocytes of old rats were investigated. In red blood cells of old rats the proton penetration into the matrix of erythrocytes showed a significant raising and the fate of labile "aging" erythrocytes in old animals compared with adult were up- regulated. These phenomena paralleled with significant up-regulation of ROS and RNS generation. Introduction for 14 days per os to old rats 0.1 mg/kg of nanocerium fully restored resistance of erythrocytes to acid hemolysis by ROS and RNS in both plasma and erythrocytes reduction. Nanocerium decreased the erythrocytes and, conversely, significantly increased the plasma's pools of H2S.


Aging/blood , Cerium/administration & dosage , Erythrocytes/drug effects , Nanoparticles/administration & dosage , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Oxygen Species/antagonists & inhibitors , Administration, Oral , Aging/pathology , Animals , Animals, Outbred Strains , Cells, Cultured , Cerium/metabolism , Erythrocytes/cytology , Erythrocytes/metabolism , Hemolysis/drug effects , Hydrogen Sulfide/blood , Nanoparticles/metabolism , Osmotic Fragility/drug effects , Oxidative Stress/drug effects , Rats , Reactive Nitrogen Species/blood , Reactive Oxygen Species/blood
16.
Eur Rev Med Pharmacol Sci ; 19(5): 879-86, 2015.
Article En | MEDLINE | ID: mdl-25807442

OBJECTIVE: Antioxidant, anti-inflammatory and venoconstrictor properties have been attributed to extracts from Aesculus hippocastanum. These unusual and diverse properties may be possibly basically linked with ability to scavenge free radicals. MATERIALS AND METHODS: The scavenging capacity of dry horse chestnut extract of and escin have been investigated in vitro against superoxide anion radicals, hydroxyl radicals, nitrites and peroxynitrite. RESULTS: In general, the activity of the whole extract against superoxide radicals did not exceed 15% at pH 7.4, but the highest inhibition (46.11%) was recorded against hydroxyl radicals at a concentration of 100 µg.ml-1; however, the activity against other radicals was lower. Escin demonstrated a better ability to counteract nitric oxide oxidation products, nitrites. However, the efficiency of the whole extract completely disappeared as the concentration increased. Both extracts showed very low activity towards peroxynitrite. Escin was even able to induce peroxynitrite formation at the lower concentrations used. CONCLUSIONS: Whole extract showed better antiradical properties compared to its main active ingredient, escin, probably due to potential synergistic interaction with a mixture of compounds present in the plant extract. These findings can be the basis of both the presentation of side-effects and the persistence of disease in spite of ongoing treatment.


Aesculus/chemistry , Antioxidants/chemistry , Escin/chemistry , Reactive Nitrogen Species/chemistry , Reactive Oxygen Species/chemistry , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Escin/pharmacology , Plant Extracts/chemistry , Plant Extracts/pharmacology , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Oxygen Species/antagonists & inhibitors
17.
Eur J Nutr ; 54(1): 109-18, 2015 Feb.
Article En | MEDLINE | ID: mdl-24682350

PURPOSE: Choline-containing dietary phospholipids, including phosphatidylcholine (PC), may function as anti-inflammatory substances, but the mechanism remains largely unknown. We investigated the effects of L-alpha-glycerylphosphorylcholine (GPC), a deacylated PC derivative, in a rodent model of small intestinal ischaemia-reperfusion (IR) injury. METHODS: Anaesthetized Sprague-Dawley rats were divided into control, mesenteric IR (45 min mesenteric artery occlusion, followed by 180 min reperfusion), IR with GPC pretreatment (16.56 mg kg⁻¹ GPC i.v., 5 min prior to ischaemia) or IR with GPC post-treatment (16.56 mg kg⁻¹ GPC i.v., 5 min prior to reperfusion) groups. Macrohaemodynamics and microhaemodynamic parameters were measured; intestinal inflammatory markers (xanthine oxidoreductase activity, superoxide and nitrotyrosine levels) and liver ATP contents were determined. RESULTS: The IR challenge reduced the intestinal intramural red blood cell velocity, increased the mesenteric vascular resistance, the tissue xanthine oxidoreductase activity, the superoxide production, and the nitrotyrosine levels, and the ATP content of the liver was decreased. Exogenous GPC attenuated the macro- and microcirculatory dysfunction and provided significant protection against the radical production resulting from the IR stress. The GPC pretreatment alleviated the hepatic ATP depletion, the reductions in the mean arterial pressure and superior mesenteric artery flow, and similarly to the post-treatments with GPC, also decreased the xanthine oxidoreductase activity, the intestinal superoxide production, the nitrotyrosine level, and normalized the microcirculatory dysfunction. CONCLUSIONS: These data demonstrate the effectiveness of GPC therapies and provide indirect evidence that the anti-inflammatory effects of PC could be linked to a reaction involving the polar part of the molecule.


Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Dietary Supplements , Disease Models, Animal , Enteritis/prevention & control , Glycerylphosphorylcholine/therapeutic use , Intestine, Small/blood supply , Reperfusion Injury/prevention & control , Adenosine Triphosphate/metabolism , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Enteritis/etiology , Gastrointestinal Agents/therapeutic use , Glycerylphosphorylcholine/administration & dosage , Intestinal Mucosa/blood supply , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Intestine, Small/immunology , Intestine, Small/metabolism , Liver/blood supply , Liver/immunology , Liver/metabolism , Male , Mesenteric Ischemia/physiopathology , Microcirculation , Oxidative Stress , Random Allocation , Rats, Sprague-Dawley , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/metabolism , Reperfusion Injury/etiology , Reperfusion Injury/immunology , Reperfusion Injury/physiopathology , Time Factors
18.
Sci Rep ; 4: 7129, 2014 Nov 20.
Article En | MEDLINE | ID: mdl-25410636

Non-thermal plasma has been recognized as a promising tool across a vast variety of biomedical applications, with the potential to create novel therapeutic methods. However, the understanding of the molecular mechanisms behind non-thermal plasma cellular effects remains a significant challenge. In this study, we show how two types of different non-thermal plasmas induce cell death in mammalian cell cultures via the formation of multiple intracellular reactive oxygen/nitrogen species. Our results showed a discrepancy in the superoxide accumulation and lysosomal activity in response to air and helium plasma, suggesting that triggered signalling cascades might be grossly different between different plasmas. In addition, the effects of ozone, a considerable component of non-thermal plasma, have been simultaneously evaluated and have revealed much faster and higher cytotoxic effects. Our findings offer novel insight into plasma-induced cellular responses, and provide a basis for better controlled biomedical applications.


Helium/chemistry , Neuroglia/cytology , Ozone/chemistry , Plasma Gases/pharmacology , 3T3 Cells , Acetylcysteine/pharmacology , Air , Animals , Annexin A5 , Antioxidants/pharmacology , Cell Death/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Lysosomes/drug effects , Membrane Potential, Mitochondrial/drug effects , Mice , Neuroglia/drug effects , Neuroglia/metabolism , Rats , Reactive Nitrogen Species/agonists , Reactive Nitrogen Species/antagonists & inhibitors , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/agonists , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Signal Transduction
19.
Hepatology ; 60(2): 687-99, 2014 Aug.
Article En | MEDLINE | ID: mdl-24710718

UNLABELLED: Caveolin-1 (Cav-1) is known to participate in many diseases, but its roles in alcoholic liver injury remain unknown. In the present study, we aimed to explore the roles of Cav-1 in protecting hepatocytes from ethanol-mediated nitrosative injury. We hypothesized that Cav-1 could attenuate ethanol-mediated nitrosative stress and liver damage through regulating epidermal growth factor receptor/signal transducer and activator of transcription 3/inducible nitric oxide synthase (EGFR/STAT3/iNOS)-signaling cascades. Ethanol-fed mice had time- and dose-dependent increases of Cav-1 in serum and liver with peak increase at 12 hours. Compared to wild-type mice, Cav-1 deficiency mice revealed higher expression of iNOS, higher levels of nitrate/nitrite and peroxynitrite, and had more serious liver damage, accompanied with higher levels of cleaved caspase-3 and apoptotic cell death in liver, and higher levels of alanine aminotransferase and aspartate aminotransferase in serum. Furthermore, the results revealed that the ethanol-mediated Cav-1 increase was in an extracellular signal-regulated kinase-dependent manner, and Cav-1 protected hepatocytes from ethanol-mediated apoptosis by inhibiting iNOS activity and regulating EGFR- and STAT3-signaling cascades. In agreement with these findings, clinical trials in human subjects revealed that serum Cav-1 level was time dependently elevated and peak concentration was observed 12 hours after binge drinking. Alcohol-induced liver lesions were negatively correlated with Cav-1 level, but positively correlated with nitrate/nitrite level, in serum of binge drinkers. CONCLUSIONS: Cav-1 could be a cellular defense protein against alcoholic hepatic injury through inhibiting reactive nitrogen species and regulating EGFR/STAT3/iNOS-signaling cascades.


Binge Drinking/metabolism , Caveolin 1/metabolism , Liver Diseases, Alcoholic/metabolism , Reactive Nitrogen Species/metabolism , Adult , Animals , Apoptosis/physiology , Binge Drinking/pathology , Caveolin 1/genetics , Central Nervous System Depressants/administration & dosage , Dose-Response Relationship, Drug , Ethanol/administration & dosage , Humans , Liver Diseases, Alcoholic/pathology , MAP Kinase Signaling System/physiology , Male , Mice , Mice, Knockout , Nitrates/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Nitrites/metabolism , Peroxynitrous Acid/metabolism , Reactive Nitrogen Species/antagonists & inhibitors , Young Adult
20.
Mol Neurobiol ; 49(1): 262-75, 2014 Feb.
Article En | MEDLINE | ID: mdl-23900742

Nitric oxide (NO) is an important inorganic molecule of the biological system owing to diverse physiological implications. NO is synthesised from a semi-essential amino acid L-arginine. NO biosynthesis is catalysed by a family of enzymes referred to as nitric oxide synthases (NOSs). NO is accused in many acute and chronic illnesses, which include central nervous system disorders, inflammatory diseases, reproductive impairments, cancer and cardiovascular anomalies. Owing to very unstable nature, NO gets converted into nitrite, peroxynitrite and other reactive nitrogen species that could lead to nitrosative stress in the nigrostriatal system. Nitrosative stress is widely implicated in Parkinson's disease (PD), and its beneficial and harmful effects are demonstrated in in vitro, rodent and primate models of toxins-induced parkinsonism and in the blood, cerebrospinal fluid and nigrostriatal tissues of sporadic PD patients. The current article updates the roles of NO and NOSs in sporadic PD and toxins-induced parkinsonism in rodents along with the scrutiny of how inhibitors of NOSs could open a new line of approach to moderately rescue from PD pathogenesis based on the existing literature. The article also provides a perspective concerning the lack of ample admiration to such an approach and how to minimise the underlying lacunae.


Nitric Oxide Synthase/metabolism , Nitric Oxide/antagonists & inhibitors , Parkinson Disease, Secondary/metabolism , Parkinsonian Disorders/metabolism , Reactive Nitrogen Species/metabolism , Animals , Humans , Methamphetamine/toxicity , Nitric Oxide/biosynthesis , Nitric Oxide/physiology , Nitric Oxide Synthase/antagonists & inhibitors , Oxidative Stress/drug effects , Oxidative Stress/physiology , Oxidopamine/toxicity , Parkinson Disease, Secondary/chemically induced , Parkinson Disease, Secondary/prevention & control , Parkinsonian Disorders/chemically induced , Reactive Nitrogen Species/antagonists & inhibitors , Rotenone/toxicity
...